RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals
Investigative Ophthalmology & Visual Science · 2025-09-23 · 66 (12) · 53
DOI: 10.1167/iovs.66.12.53 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, published on 2025-09-23. Written by Eline Van Vooren and 37 co-authors. Institution: Department of Biomolecular Medicine, Ghent University, Ghent, Belgium. Major MEDLINE topics: cis-trans-Isomerases, Macular Degeneration, Mutation. Cited 4 times so far (Crossref); 53 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
Recessive RPE65-associated retinopathy is a well-known target for gene therapy, whereas dominant RPE65-associated retinopathy, due to the Irish founder variant p.(D477G), has been reported only once until now and is very rare. Here, we present the discovery of a novel, second dominant RPE65-associated retinopathy caused by variant c.1555G>A, p.(E519K).
Methods
Genomic data was investigated in a Belgian discovery cohort (n = 2873) and an international replication cohort (n = 18,796) with inherited retinal disease (IRD). Heterozygous p.(E519K) individuals underwent extensive phenotyping. Haplotype phasing was based on long-read sequencing and microsatellite analysis. Variant p.(E519K) was assessed in vitro using an enzymatic assay, Western blotting, co-immunoprecipitation, cellular thermal shift assay (CETSA), minigene assays, and in silico using protein modeling (AlphaFold).
Results
The monoallelic p.(E519K) variant was found in 83 affected individuals from Belgium, the Netherlands, France, and Canada, all of European ancestry. A shared region of 464 kilobases (kb) confirmed a founder effect. Variant p.(E519K) lowers RPE65 protein expression and enzymatic activity, with altered protein stability predicted and experimentally confirmed. Genotype-phenotype data support dominant inheritance and phenotypic variability, respectively, characterized by late-onset macular dystrophy with two main subtypes.
Conclusions
The discovery of a dominant RPE65-IRD due to founder variant p.(E519K) reduces the diagnostic gap in dominant IRD and highlights a novel target for therapy.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
- Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
- Department of Head and Skin, Ghent University, Ghent, Belgium.
- Department of Ophthalmology, Ghent University Hospital, Ghent, Belgium.
- Laboratory of Retinal Cell and Molecular Biology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States.
- University of Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, Lille, France.
Cite
APA
Van Vooren, E., Van Den Broeck, F., Mahieu, Q., Geens, E., Van Heetvelde, M., De Bruyne, M., Van de Sompele, S., Uppal, S., Poliakov, E., Dhaenens, C. M., Gregory-Evans, C. Y., Hoefsloot, L., Gonzalez, A. I., Kohl, S., Zuleger, T., Demaret, T., Tuupanen, S., Ruys, J., Van Os, L., …, & Dominant RPE65-p.(E519K) Consortium (2025). RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals. Investigative Ophthalmology & Visual Science, 66(12), 53. https://doi.org/10.1167/iovs.66.12.53
Vancouver
Van Vooren E, Van Den Broeck F, Mahieu Q, Geens E, Van Heetvelde M, De Bruyne M, et al. RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals. Investigative Ophthalmology & Visual Science. 2025;66(12):53. doi:10.1167/iovs.66.12.53
BibTeX
@article{VanVooren2025,
author = {Van Vooren, Eline and Van Den Broeck, Filip and Mahieu, Quinten and Geens, Eline and Van Heetvelde, Mattias and De Bruyne, Marieke and Van de Sompele, Stijn and Uppal, Sheetal and Poliakov, Eugenia and Dhaenens, Claire-Marie and Gregory-Evans, Cheryl Y and Hoefsloot, Lies and Gonzalez, Adriana Iglesias and Kohl, Susanne and Zuleger, Theresia and Demaret, Tanguy and Tuupanen, Sari and Ruys, Joke and Van Os, Luc and Platteau, Elise and Jacob, Julie and Vermeer, Sascha and Postelmans, Laurence and Dahan, Karin and Maystadt, Isabelle and Rasquin, Florence and Thiadens, Alberta A H J and Stephenson, Kirk A J and Sheri, Narin and Smirnov, Vasily and MacDonald, Ian M and Gregory-Evans, Kevin and Redmond, T Michael and De Zaeytijd, Julie and Leroy, Bart P and Bauwens, Miriam and De Baere, Elfride and Dominant RPE65-p.(E519K) Consortium, Dominant RPE65-p.(E519K) Consortium},
title = {RPE65 Variant p.(E519K) Causes a Novel Dominant Adult-Onset Maculopathy in 83 Affected Individuals},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
volume = {66},
number = {12},
pages = {53},
doi = {10.1167/iovs.66.12.53}
}
EUVIMED